Cargando…
Setd2 inactivation sensitizes lung adenocarcinoma to inhibitors of oxidative respiration and mTORC1 signaling
SETD2 is a tumor suppressor that is frequently inactivated in several cancer types. The mechanisms through which SETD2 inactivation promotes cancer are unclear, and whether targetable vulnerabilities exist in these tumors is unknown. Here we identify heightened mTORC1-associated gene expression prog...
Autores principales: | Walter, David M., Gladstein, Amy C., Doerig, Katherine R., Natesan, Ramakrishnan, Baskaran, Saravana G., Gudiel, A. Andrea, Adler, Keren M., Acosta, Jonuelle O., Wallace, Douglas C., Asangani, Irfan A., Feldser, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006211/ https://www.ncbi.nlm.nih.gov/pubmed/36899051 http://dx.doi.org/10.1038/s42003-023-04618-3 |
Ejemplares similares
-
Off and Back-On Again: A Tumor Suppressor’s Tale
por: Acosta, Jonuelle, et al.
Publicado: (2018) -
p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism
por: Acosta, Jonuelle, et al.
Publicado: (2023) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016) -
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018) -
Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2
por: Kosillo, Polina, et al.
Publicado: (2022)